Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Purple Biotech (PPBT) Prepaid Assets (2017 - 2025)

Purple Biotech has reported Prepaid Assets over the past 6 years, most recently at $1.1 million for Q4 2022.

  • Quarterly Prepaid Assets fell 10.21% to $1.1 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2022, down 10.21% year-over-year, with the annual reading at $1.1 million for FY2022, 10.21% down from the prior year.
  • Prepaid Assets was $1.1 million for Q4 2022 at Purple Biotech, down from $1.2 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $2.4 million in Q1 2022 and troughed at $344000.0 in Q2 2018.
  • The 5-year median for Prepaid Assets is $1.2 million (2020), against an average of $1.3 million.
  • Year-over-year, Prepaid Assets skyrocketed 233.94% in 2018 and then crashed 48.77% in 2020.
  • A 5-year view of Prepaid Assets shows it stood at $1.8 million in 2018, then increased by 4.21% to $1.9 million in 2019, then crashed by 48.77% to $977000.0 in 2020, then surged by 30.3% to $1.3 million in 2021, then fell by 10.21% to $1.1 million in 2022.
  • Per Business Quant, the three most recent readings for PPBT's Prepaid Assets are $1.1 million (Q4 2022), $1.2 million (Q3 2022), and $1.4 million (Q2 2022).